Why the study?
Does labetalol reduce blood pressure in patients with hypertension?
Does labetalol reduce blood pressure in patients with hypertension?
Labetalol at 600 mg daily provides significant blood pressure reduction across all postures with mild side effects in patients with mild to moderately severe hypertension.
Answers are grounded in this paper and cite their sources.
Supports labetalol 600 mg daily for posture-independent BP control in hypertension; reinforces RCT efficacy for mild-moderate cases.
The antihypertensive effect of labetalol, a new alpha- and beta-adrenoceptor inhibiting agent, was studied in 20 patients in a double-blind crossover trial. A dose of 300 mg daily reduced blood pressure only moderately in the supine position, though in the sitting and standing positions the effect was more pronounced. A dose of 600 mg daily produced statistically significant and clinically relevant reductions in blood pressure in all positions studied. The effect on heart rate was small and of significance only in reducing the heart rate increment due to a change in posture. Side effects were mild: only one patient complained of postural dizziness with the higher dose. We conclude that labetalol is useful in the treatment of mild and moderately severe hypertension.
No takes yet. Share an insight, caveat, or question.
Frick et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: